BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
PRKCA
,
Apoptosis
,
Breast Cancer
,
Kidney
,
Biofuel
,
Ciprofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Leishmania guyanensis
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for Leishmania guyanensis
Explore Curated Studies Results
Literature
Most Relevant Literature
Treatment of cutaneous leishmaniasis with a sequential scheme of pentamidine and tamoxifen in an are…
Potency and Preclinical Evidence of Synergy of Oral Azole Drugs and Miltefosine in an Ex Vivo Model …
Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication.
Leishmania guyanensis M4147 as a new LRV1-bearing model parasite: Phosphatidate phosphatase 2-like p…
Sequencing of hsp70 for discernment of species from the Leishmania (Viannia) guyanensis complex from…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective S…
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous L…
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmani…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ